Medical Company Announces Option Agreement For Dietary Supplement Technology
FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization.
On June 11, 2024, FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company focused on creating innovative biotech solutions, announced an exclusive option agreement with the University of Southern California (USC). This agreement grants FSD Pharma the right to exclusively assess a novel dietary supplement technology developed at USC, with the aim of determining its feasibility for commercialization. This strategic partnership signifies a pivotal step toward potentially enhancing dietary supplement formulations and expanding market reach. $FSD Pharma Inc(HUGE.CA$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
